Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0152030 (
skin irritation
)
2,146
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The purpose of the present study was to evaluate compatibility between aluminium Finn Chambers and various mercurials either dissolved in water or dispersed in petrolatum (at the concentrations used in patch test clinics). Aluminium chambers were corroded by aqueous solutions of mercuric oxycyanide, ammoniated
mercury
and thiomersal, but not by solutions of other mercurials. No corrosion was noted when mercurials had been dispersed in petrolatum, even after 6 months at 37 degrees C. Patch test series of mercurials dispersed in petrolatum were applied on the skin of guinea pigs and in man for 48 h, using aluminium Finn Chambers. No clinical sign of
skin irritation
was observed. It can be concluded that aluminium Finn Chambers may be safely used for patch testing mercurials if these are dispersed in petrolatum.
...
PMID:An evaluation of the compatibility between aluminium Finn Chambers and various mercurials dissolved in water or dispersed in petrolatum. 398 16
Diseases caused by occupational exposure to sensitizing metals including platinum (Pt), rhodium (Rh), nickel (Ni), chromium (Cr), cobalt (Co), gold (Au),
mercury
(Hg), zirconium (Zr) and beryllium (Be) are reviewed. Allergic reactions induced by the metals are described according to the classification by Coombs and Gell. Metals with unproven sensitizing potential are not discussed if reports on these are either very rare or devoid of convincing evidence for allergic involvement. The sensitizing metals are haptens which are not themselves able to act as antigens. There is evidence that combination of the metals with circulating or tissue protein gives rise to new antigens. An alternative hypothesis is that these metals interfere with the antigen recognition step of the immune response. Immunomodulatory effects or immunotoxicity of the metals may be also involved in metal-induced hypersensitivity. Occupational exposure to Pt, Rh, Ni, Cr, and Co causes allergic asthma via type I allergic reaction in which serum from affected individuals shows specific IgE antibodies against mental-human serum albumin conjugates. Some rheumatoid arthritis patients treated with gold salt therapy develop glomerulonephritis, thrombocytopenia, or agranulocytosis, which arise from type II and/or type III allergic reactions. Occupational exposure to
mercury
causes glomerulonephritis in which involvement of type III reaction is suggested. Type IV hypersensitivity reaction of the skin also takes place following exposure to the metals: allergic contact dermatitis is evoked by exposure to Ni, Cr, Co, Rh, and Hg; cutaneous granuloma is formed by contact with Zr and Be. Be is also a sensitizer of the lungs, resulting in granulomatous disease. Diagnosis of metal-induced allergic diseases is made on the basis of allergological tests with metal antigens including skin tests, radioallergosorbent test for specific antibody, lymphocyte transformation test, macrophage migration inhibition test, and provocation test. Atopy is a predisposing factor and smoking is a risk factor for developing metal-induced asthma. Evidence for genetic factors in the development of metal contact dermatitis is conflicting, although animal models implicate genetic factors in skin sensitization with some metals and respiratory sensitization with Be.
Skin irritation
, forearm injury, complication with atopic dermatitis and concomitant sensitization to other agents are determinants for prognosis of the dermatitis. Epidemiological reports of occupational diseases from allergic reactions to metals in industries are reviewed with respect to prevalence and allergic manifestations. There is a report on a clinical trial of hyposensitization with Pt in a platinum asthma patient. Predictive methods for evaluating sensitization potential of metals have been developed and new methods, which quantify potential more objectively, are sought.
...
PMID:[Occupational diseases caused by exposure to sensitizing metals]. 851 Mar 47
Acid Violet 43 is an anthraquinone color that may be used as a colorant in cosmetic formulations that are hair dyes, colors, and coloring rinses. Batches of Acid Violet 43 that are certified to meet the United States Food and Drug Administration (U.S. FDA) specifications are termed Ext. D & C Violet No. 2. Hair dyes and colors containing Acid Violet 43 are considered coal tar ingredients and, as such, routinely bear a caution statement regarding potential
skin irritation
and instructions for determining whether the product causes
skin irritation
in any given individual. Expected concentrations of use are less than or equal to 1%. Impurities include anthracenedione derivatives, p-toluidine, and p-toluidine sulfonic acid, as well as heavy metals. Based on extensive safety test data, the U.S. FDA has established specifications (including limits on impurities) for Ext. D & C Violet No. 2 that allow its use in any cosmetic. It is the certified color (Ext. D & C Violet No. 2) that has been evaluated in the following safety tests. Oral toxicity tests do not demonstrate significant acute toxicity. In a short-term dermal toxicity study using guinea pigs and a subchronic dermal toxicity study using rabbits, no signs of systemic toxicity and no significant local skin reactions were noted. This ingredient was not genotoxic in bacterial assays, nor was it carcinogenic when applied to mouse skin at a 1% concentration. Accordingly, Acid Violet 43 was determined to be safe for use in hair dye formulations, when impurities are limited as follows: < or = 18% volatile matter (at 135 degrees C) and chlorides and sulfates (calculated as sodium salts); < or = 0.4% water-insoluble matter; < or = 0.2% 1-hydroxy-9,10-anthracenedione; < or = 0.2% 1,4-dihydroxy-9,10-anthracenedione; < or = 0.1% p-toluidine; < or = 0.2% p-toluidine sulfonic acids, sodium salts; < or = 1% subsidiary colors; < or = 20 ppm lead (as Pb); < or = 3 ppm arsenic (as As); < or = 1 ppm
mercury
(as Hg); and with > or = 80% total color.
...
PMID:Final report on the safety assessment of Acid Violet 43. 1176 30
The aim of this research project was to learn more about work-related health risks among dental assistants in Flanders, Belgium. Forty-seven dental assistants completed an extensive questionnaire concerning ionized radiation, protection against infection and exposure to chemicals such as
mercury
, disinfectants and acrylates. Collective and personal means of protection, musculoskeletal disorders and work-related stress were also evaluated. Pain in the lower back, neck pain and shoulder pain were reported by, respectively, 15%, 17% and 22% of the respondents. Eczema resulting from
skin irritation
or contact-allergy was reported by 13%. Twenty-three percent of the assistants did not consistently make use ofa radiation badge; 80% wore a mouth mask and 33% wore protective glasses; and 82% was vaccinated against hepatitis B. Almost 10% reported verbal or physical aggression by patients. The mean stress score was 3.95 on a scale from 0 to 10. The results may contribute to the formulation of a number of recommendations for the improvement of the health of dental assistants.
...
PMID:[Work related health risks among dentist's assistants in Flanders, Belgium]. 2188 6
Silver sulfadiazine has been frequently used as an antibacterial agent for topical treatment of partial thickness burn wounds. In this study, we present the preparation of silver sulfadiazine microsponges by w/o/w emulsion solvent evaporation method. Formulation variables were optimized by using 3
2
factorial design. The optimized microsponges were characterized by FTIR, DSC, PXRD, particle size analysis, SEM analysis and
mercury
intrusion porosimetry studies. Viscosity, texture analysis and ex vivo drug deposition study of optimized microsponge loaded gel were also evaluated. The safety of the optimized gel was assessed by MTT assay using epidermal keratinocyte (HaCaT) and mouse embryonic fibroblast (NIH-3T3) cell lines. In vitro antibacterial studies were carried out to compare the antibacterial inhibitory efficiency of the optimized gel against the commercial product. The efficacy of the optimized gel was evaluated by the partial thickness (second degree) burn wound model in mice. Optimized microsponge loaded gel enhanced the drug retaining capacity in the skin layers, by 3 fold higher to that of a commercial product. The antibacterial inhibitory efficiency of optimized gel was similar to the commercial product against the Staphylococcus aureus and Pseudomonas aeruginosa. Optimized gel showed reduced frequency of application, no
skin irritation
, low cytotoxicity on dermal cell lines and enhanced wound contraction.
...
PMID:Development and evaluation of silver sulfadiazine loaded microsponge based gel for partial thickness (second degree) burn wounds. 2769 4